TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus

Did you know that TIEFENBACHER GROUP heavily invests in its own manufacturing facilities to secure an efficient and reliable supply of our high-quality pharmaceuticals for patients around the world?

As fully integrated pharmaceutical company, we offer a competitive supply chain management through our two own manufacturing plants in India and Cyprus. Our facilities are equipped with sophisticated technology from the first manufacturing step throughout to the last packaging step and warehousing. We are flexible to manage small batch as well as high volume productions. While our SPC waiver site in Cyprus is your perfect plant for high volume production made in Europe, our FDA approved site in India is your ideal fit for special technologies and small batch production. Both sites are currently further enlarging their production capacities, equipment, and warehouse storage – to drive efficiency and meet the growing demand of our customers. Our two own manufacturing sites as well as our global network of contract manufacturers allow us to manufacture nearly any kind of formulation and dosage form. No matter if a controlled drug or a special dosage form – our about 60 years experience and our excellent know how in terms of regulatory and quality requirements guarantee the best possible supply chain for you. All our plants are equipped with highly qualified professionals and highest safety standards. This ensures full compliance with Good Manufacturing Practice (GMP). Apart from the most important governmental approvals, our sites are periodically inspected by leading pharmaceutical companies.

For further information about our manufacturing facilities and innovative health care solutions please contact TIEFENBACHER GROUP: info@aet.eu or visit us on: www.tiefenbachergroup.com